Diarrhea News and Research

Latest Diarrhea News and Research

Colorectal cancer deaths on the rise among Americans: JAMA study

A new study from the American Cancer Society has found that more people living in the United States of America are dying from colon and rectal cancers around the age of 50 years when they are supposed to officially begin screening for these cancers. The new study is published in the JAMA, the Journal of the American Medical Association.

10 Aug 2017

Increase in reported cases of Cyclospora infections compared to last year, CDC reports

The Centers for Disease Control and Prevention (CDC) has released a Health Alert Network (HAN) Health Advisory on 7th August 2017, Monday, in order to alert the health care facilities and the public health department on the increase in the reported cases of cyclosporiasis.

9 Aug 2017

Scientists take steps to inhibit impact of E. coli on human health

By understanding the functional differences between proteins expressed by two E. coli strains, researchers at Kansas State University are exploring new opportunities to inhibit their impacts to human health.

8 Aug 2017

Protein-rich diet may foster more tolerant, less inflammatory gut environment

Immune cells patrol the gut to ensure that harmful microbes hidden in the food we eat don't sneak into the body. Cells that are capable of triggering inflammation are balanced by cells that promote tolerance, protecting the body without damaging sensitive tissues.

3 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

UM SOM awarded $2.47 million grant to develop vaccine against Shigella, ETEC infections

The University of Maryland School of Medicine has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal diseases in young children in developing countries and a common cause of "traveler's diarrhea" among travelers to these countries.

3 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017

Breastfeeding is currently failing to meet recommended standards across the globe, UNICEF and WHO report reveals

A new report released by the United Nations Children's Fund, UNICEF, and the World Health Organization, WHO, in alliance with the Global Breastfeeding Collective – a new initiative to escalate the rates of global breastfeeding – suggests that the recommended standards for breastfeeding are not completely achieved by any countries in the world.

2 Aug 2017

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved updated labeling for Epclusa (sofosbuvir 400mg/velpatasvir 100mg), the first all-oral, pan-genotypic, once-daily single tablet regimen (STR) for the treatment of adults with chronic hepatitis C virus (HCV) infection, to include use in patients co-infected with HIV.

1 Aug 2017

Two new discoveries provide better understanding of how bacteria resist antibiotics

Two new discoveries from Edward Yu's Iowa State University laboratory are adding to the scientific understanding of how bacteria resist antibiotics.

1 Aug 2017

Ultra-sensitive C. difficile toxin assay may be critical tool for improving diagnosis of infectious disease

Findings presented at the American Society for Microbiology's ASM Microbe conference show that the ultra-sensitive Clostridium difficile toxin A/B assay in development for use on the Sgx Clarity™ system offers excellent sensitivity and may be a critical tool for improving the diagnosis of this life-threatening infection.

29 Jul 2017

Genetic test to predict IBD severity in children

Inflammatory bowel disease (IBD) is a chronic relapsing inflammation of the gastrointestinal tract with abdominal pain and diarrhea being the most common symptoms. It can be challenging to diagnose as gastrointestinal complaints mimicking IBD are common.

26 Jul 2017

Living in rural households lowers person's risk of developing IBD, study finds

Living in rural households decreases a person's risk of developing inflammatory bowel disease (IBD), particularly for young children and adolescents, according to a new study by researchers at the Children's Hospital of Eastern Ontario Research Institute, Institute for Clinical Evaluative Sciences, and the Canadian Gastro-Intestinal Epidemiology Consortium.

25 Jul 2017

Multistate Salmonella outbreak linked to Maradol Papaya: CDC reports

A total of 47 people have been infected with Salmonella Kiambu infections from 12 different states as of 21st July 2017, reports the CDC. Of these, 12 have had to be hospitalized and one person from New York City succumbed to the infection. Maradol papayas have been found to be the likely source of this infection and the CDC has recommended people not to consume these until its clear.

24 Jul 2017

Diarrhea News and Research

Latest Diarrhea News and Research

Colorectal cancer deaths on the rise among Americans: JAMA study

Increase in reported cases of Cyclospora infections compared to last year, CDC reports

Scientists take steps to inhibit impact of E. coli on human health

Protein-rich diet may foster more tolerant, less inflammatory gut environment

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

UM SOM awarded $2.47 million grant to develop vaccine against Shigella, ETEC infections

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Breastfeeding is currently failing to meet recommended standards across the globe, UNICEF and WHO report reveals

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Two new discoveries provide better understanding of how bacteria resist antibiotics

Ultra-sensitive C. difficile toxin assay may be critical tool for improving diagnosis of infectious disease

Genetic test to predict IBD severity in children

Living in rural households lowers person's risk of developing IBD, study finds

Multistate Salmonella outbreak linked to Maradol Papaya: CDC reports

Global multi-stakeholder partnerships improve health of women, children, and adolescents

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

Haiti to receive $40.5 million from the UN to combat cholera epidemic

Scientists reveal key role of excess gut calcium in C. diff infections

Ground-breaking new breast cancer drugs have manageable toxicity profile for most patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Diarrhea News and Research

Latest Diarrhea News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in